 Today, I have the privilege of getting an update from Dr. Francis Dubay from Zen Graphene Solutions. How are you today, Francis? I'm very well. Happy to be here, Tracy. Well, I'll tell you, your stock has had a beautiful movement here in this last year. I think what was your low in the last 52 weeks? Low is $0.39 cents and you're $0.306 right now, Canadian? Correct. It's been a good year. Now, I know you're all about achieving milestones, so I know you don't want to talk about the stock price. You don't want to talk about how much you've gotten done. So let's talk about your recent announcement with TrevorRx, your successful inhalation safety testing of Zengard enhanced surgical masks. Let's talk. Let's start there, please. Absolutely. So one of the things that happened with Health Canada and the masks that came out of Quebec were really put a spin on the industry where Health Canada was concerned about the safety of the mask and having graphene particles coming off the mask and being inhaled. And what that would do from a safety perspective? Well, we had our masks tested and we were very happy to report to Health Canada that none, we had zero emissions from our mask of graphene or graphene oxide. So for consumers, that's a great safety profile. They can wear this mask and not worry about any health issues from a safety impact. And then, of course, we've been demonstrating how much better this mask is compared to what's out there. So we really believe that this will be a leading product in the marketplace. Well, of course, the market responded very favorably to this news. But since this news, you also added some very disruptive news. You announced a diesel fuel additive that improves the performance of diesel fuel, just changing the topic completely. Okay. That was exciting news as well. The market also responded positively to that. So can you tell us more about this technology, please? Yeah. Again, we've been focused on R&D for the last three years. This project is probably about two years in the making. There was a few reports out there, obscure research that we found where graphene or graphene oxide could improve the performance of diesel or biodiesel fuels. And we did some preliminary testing and confirmed some of that data. But the challenge was really in finding a way to keep the graphene or the graphene oxide soluble or stable in the fuel. And that's really what we filed a patent on is finding a way and filing a patent for it to take the graphene or graphene oxide. We don't worry about too much of what we're doing here. But finding a way to keep that very stable in fuel, we've got over three months of data here that's showing that our fuel additive is very stable in there. It's adding around 10%, and we've seen some RPM range be as high as 20% on average. So this could be very substantial. The world is all about ESG right now, environmentally, more sound products. Fuel consumption is a big issue. So when you consider that there's about a trillion liters of diesel that gets consumed every year, if we can make that diesel fuel 10% to 20% better, we're going to have a significant impact on the amount of emissions, greenhouse gases that get produced by that. So there's a green angle here to this. There's a economical angle to this. We're very proud of what we're doing in that field, and we think we can actually make a difference here for all of us from an environmental standpoint. Of course, you've touched on ESG and how everyone's talking about ESG. Have you been speaking to any funds recently, Francis, or can you comment on that? We've had multiple discussions, and we're getting more interest from institutions and high network brokers, individuals. ESG is something that comes up often, and we're happy to talk about how we feel a lot of those mandates. If you look at our corporate presentation, we look at the UN ESG goals, and we feel I think 6 or 7 out of the 14 mandates that they have for ESG. So there's a lot of ESG, and that's part of our DNA for Zen Graphene, and using our products to help where we can. We really want to let investors know that we're focused on that. Speaking of focus, of course, right now you have real revenue coming in from Sengard, these enhanced surgical masks. Can you tell us how large this market is? And I mean, with COVID-19, a lot of people not wearing masks, for instance, in the American audience, how is this going to impact your sales? Or is this something that has a nice tight niche for you? We definitely have a nice tight niche. So the mask we've developed is an ASTM level 3 mask. In terms of surgical masks, you can't get a higher designation than that. So this is really aimed at hospitals, long-term care residences, health care professionals. We believe that those markets are still going to be concerned, you know, dealing with public all the time in health care settings. They're definitely going to want to keep wearing the best mask available. You know, we know that during 2020, we hit somewhere in the neighborhood of 1.5 trillion masks a year in consumption worldwide. That's a massive number. Cut that by half. We're still at 750 billion masks a year. If we capture 1% of that, that's still a big market for us. So we're really going after that high-end market, the health care market. And we believe they will want the best protection because they're the ones that are facing people that either have COVID or suspected of having COVID. So we don't see any challenges there from the market demand side. Well, compound that, of course, with the diesel fuel market. How large is that market? As I think I mentioned earlier, it's about a 1 trillion liter a year market. So even if we get 10% of that, 5% of that, that's a big market in itself. And if we can, you know, convince government that this is a better way to create fuel and help the environment. You know, we hope that we can get some regulatory help as well along the way, not just to prove the fuel additive, but to potentially mandate it into law. So we'll see where that goes down the road. But we're pretty excited about that market. Oh, I heard the trillion. I just wanted to make sure everyone out there and investor Intel land heard that as well. So we are delighted to have an update from you, Frances. Can you just tell us what we as shareholders should anticipate this next quarter? I mean, is it too late to get in on the Zen game? I mean, your stock has moved over 369% the last time we calculated. And I believe that number is actually low compared to what it is today. What I'll tell you is that we feel like we're just at the beginning. We're pre-revenue right now. You know, we're hoping for health care approval here in the next little while. But we've got a lot of other developments. We're not sort of a one trick pony, if you will. There's a lot of developments that we're going to be announcing over the summer. So we're not taking a hiatus here during the summer like some companies. We are full out during the summer and you're going to see a new flow that reflects that. So it's going to be an exciting summer for Zen and our shareholders. Well, thank you, Frances, so much for the update. And congratulations on all your latest announcements. Very exciting for all of us that are shareholders for Zen Graphene Solutions. Thank you. Thank you for your time, Tracy. Have a great day.